共 145 条
[1]
Alderman MH(1999)Diabetes and cardiovascular events in hypertensive patients Hypertension 33 1130-1134
[2]
Cohen H(2003)Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 3160-3167
[3]
Madhavan S(1993)Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 434-444
[4]
Genuth S(2004)Adverse prognostic significance of new diabetes in treated hypertensive subjects Hypertension 43 963-969
[5]
Alberti KG(2000)Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 145-153
[6]
Bennett P(2005)Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials J Am Coll Cardiol 46 821-826
[7]
Stamler J(2002)Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol Lancet 359 995-1003
[8]
Vaccaro O(2004)Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Lancet 363 2022-2031
[9]
Neaton JD(2004)Renin–angiotensin system and angiotensin receptor blockers in the metabolic syndrome Circulation 110 1507-1512
[10]
Wentworth D(2008)Aliskiren Circulation 118 773-784